Skip to main content

Home/ Health and Fitness Club/ Group items tagged lack-of-new-antibiotics-being-developed

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
pharmacybiz

OHE report estimates global investment of £3.5bn for r&d - 0 views

www.pharmacy.biz/-development-of-new-antibiotic

ohe-reports pharmacy-business Incentivising-new-antibiotics lack-of-new-antibiotics-being-developed latest-antibiotics-2023 development-of-new-antibiotics

shared by pharmacybiz on 04 Apr 23 - No Cached
  • pharmacybiz on 04 Apr 23
     
    The current structure of global incentives to develop new antibiotics is insufficient and requires urgent resolution revealed a new report 'Incentivising new antibiotics' by the Office of Health Economics (OHE). OHE analysis demonstrates that on a global level, it is estimated that an effective 10-year incentive would require £3.5bn ($4.2bn) to adequately cover the entire research and development process for a new antibiotic. The report considers how health systems in the UK and around the world can stimulate the research and development (R&D) of new antibiotics. In 2020, the National Institute for Health and Care Excellence (NICE) and NHS England initiated an Antimicrobial Resistance pilot with the aim of incentivising pharmaceutical companies to develop new antibiotics by addressing the issues associated with reimbursement, which historically has deterred companies from pursuing AMR research.
1 - 1 of 1
Showing 20▼ items per page